These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 35689351)

  • 1. Coronavirus disease 2019 (COVID-19) update: From metabolic reprogramming to immunometabolism.
    Rudiansyah M; Jasim SA; Mohammad Pour ZG; Athar SS; Jeda AS; Doewes RI; Jalil AT; Bokov DO; Mustafa YF; Noroozbeygi M; Karampoor S; Mirzaei R
    J Med Virol; 2022 Oct; 94(10):4611-4627. PubMed ID: 35689351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How could we forget immunometabolism in SARS-CoV2 infection or COVID-19?
    Kumar V
    Int Rev Immunol; 2021; 40(1-2):72-107. PubMed ID: 33155525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS.
    Lupu L; Palmer A; Huber-Lang M
    Front Immunol; 2020; 11():584514. PubMed ID: 33101314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.
    Barbieri A; Robinson N; Palma G; Maurea N; Desiderio V; Botti G
    Front Immunol; 2020; 11():588724. PubMed ID: 33117402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting immunometabolism against acute lung injury.
    Ning L; Shishi Z; Bo W; Huiqing L
    Clin Immunol; 2023 Apr; 249():109289. PubMed ID: 36918041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of immunometabolism in macrophage polarization and its impact on acute lung injury/acute respiratory distress syndrome.
    Wang L; Wang D; Zhang T; Ma Y; Tong X; Fan H
    Front Immunol; 2023; 14():1117548. PubMed ID: 37020557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting immunometabolism to treat COVID-19.
    O'Carroll SM; O'Neill LAJ
    Immunother Adv; 2021 Jan; 1(1):ltab013. PubMed ID: 34240083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Macrophage Immunometabolism: A New Approach to Fight Infections.
    Gauthier T; Chen W
    Front Immunol; 2022; 13():780839. PubMed ID: 35154105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation research sails through the sea of immunology to reach immunometabolism.
    Kumar V
    Int Immunopharmacol; 2019 Aug; 73():128-145. PubMed ID: 31096130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR2 Signaling Restricts SARS-CoV-2 Infection.
    Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
    mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the NLRP3 Inflammasome in Severe COVID-19.
    Freeman TL; Swartz TH
    Front Immunol; 2020; 11():1518. PubMed ID: 32655582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Nasal and Lung Tissues Infected
    Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
    J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).
    Mohammed RN; Tamjidifar R; Rahman HS; Adili A; Ghoreishizadeh S; Saeedi H; Thangavelu L; Shomali N; Aslaminabad R; Marofi F; Tahavvori M; Danshina S; Akbari M; Ercan G
    Cell Commun Signal; 2022 Jun; 20(1):79. PubMed ID: 35655192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe COVID-19: what have we learned with the immunopathogenesis?
    Bordallo B; Bellas M; Cortez AF; Vieira M; Pinheiro M
    Adv Rheumatol; 2020 Sep; 60(1):50. PubMed ID: 32962761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics.
    Qin H; Zhao A
    Protein Cell; 2020 Oct; 11(10):707-722. PubMed ID: 32519302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 triggering autoimmune diseases.
    Mobasheri L; Nasirpour MH; Masoumi E; Azarnaminy AF; Jafari M; Esmaeili SA
    Cytokine; 2022 Jun; 154():155873. PubMed ID: 35461172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome.
    Kosyreva A; Dzhalilova D; Lokhonina A; Vishnyakova P; Fatkhudinov T
    Front Immunol; 2021; 12():682871. PubMed ID: 34040616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D3 as Potential Treatment Adjuncts for COVID-19.
    Malaguarnera L
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33202670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.
    Kumar R; Rathi H; Haq A; Wimalawansa SJ; Sharma A
    Virus Res; 2021 Jan; 292():198235. PubMed ID: 33232783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome.
    Hue S; Beldi-Ferchiou A; Bendib I; Surenaud M; Fourati S; Frapard T; Rivoal S; Razazi K; Carteaux G; Delfau-Larue MH; Mekontso-Dessap A; Audureau E; de Prost N
    Am J Respir Crit Care Med; 2020 Dec; 202(11):1509-1519. PubMed ID: 32866033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.